These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

567 related articles for article (PubMed ID: 11084576)

  • 21. Resistin inhibits glucose uptake in L6 cells independently of changes in insulin signaling and GLUT4 translocation.
    Moon B; Kwan JJ; Duddy N; Sweeney G; Begum N
    Am J Physiol Endocrinol Metab; 2003 Jul; 285(1):E106-15. PubMed ID: 12618360
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decreased expression of the GLUT4 glucose transporter protein in adipose tissue during pregnancy.
    Okuno S; Akazawa S; Yasuhi I; Kawasaki E; Matsumoto K; Yamasaki H; Matsuo H; Yamaguchi Y; Nagataki S
    Horm Metab Res; 1995 May; 27(5):231-4. PubMed ID: 7642174
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanisms of antihyperglycemic effects of moxonidine in the obese spontaneously hypertensive Koletsky rat (SHROB).
    Ernsberger P; Ishizuka T; Liu S; Farrell CJ; Bedol D; Koletsky RJ; Friedman JE
    J Pharmacol Exp Ther; 1999 Jan; 288(1):139-47. PubMed ID: 9862764
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Continually high insulin levels impair Akt phosphorylation and glucose transport in human myoblasts.
    Bertacca A; Ciccarone A; Cecchetti P; Vianello B; Laurenza I; Maffei M; Chiellini C; Del Prato S; Benzi L
    Metabolism; 2005 Dec; 54(12):1687-93. PubMed ID: 16311104
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of a 2-day very low-energy diet on skeletal muscle insulin sensitivity in obese type 2 diabetic patients on insulin therapy.
    Jazet IM; Ouwens DM; Schaart G; Pijl H; Keizer H; Maassen JA; Meinders AE
    Metabolism; 2005 Dec; 54(12):1669-78. PubMed ID: 16311102
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of insulin receptor substrate-1 G972R variant with baseline characteristics of the patients with gestational diabetes mellitus.
    Tok EC; Ertunc D; Bilgin O; Erdal EM; Kaplanoglu M; Dilek S
    Am J Obstet Gynecol; 2006 Mar; 194(3):868-72. PubMed ID: 16522427
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effects of insulin receptor substrate-1 and its serine phosphorylation and tyrosine phosphorylation on insulin resistance in skeletal muscle cells in the state of sepsis: experiment with rats].
    Yan XW; Li WQ; Wang XD; Li JS; Li N
    Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(41):2922-7. PubMed ID: 17288791
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distinct protein tyrosine phosphorylation during mitogenesis induced in quiescent SV40-transformed 3T3 T cells by insulin or vanadate.
    Wang H; Scott RE
    J Cell Physiol; 1994 Mar; 158(3):408-16. PubMed ID: 8126065
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insulin resistance induced by tumor necrosis factor-alpha in myocytes and brown adipocytes.
    Lorenzo M; Fernández-Veledo S; Vila-Bedmar R; Garcia-Guerra L; De Alvaro C; Nieto-Vazquez I
    J Anim Sci; 2008 Apr; 86(14 Suppl):E94-104. PubMed ID: 17940160
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of muscle insulin resistance by selective inhibition of GSK-3 in Zucker diabetic fatty rats.
    Henriksen EJ; Kinnick TR; Teachey MK; O'Keefe MP; Ring D; Johnson KW; Harrison SD
    Am J Physiol Endocrinol Metab; 2003 May; 284(5):E892-900. PubMed ID: 12517738
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polymorphisms of insulin receptor substrate 1 and beta3-adrenergic receptor genes in gestational diabetes and normal pregnancy.
    Fallucca F; Dalfrà MG; Sciullo E; Masin M; Buongiorno AM; Napoli A; Fedele D; Lapolla A
    Metabolism; 2006 Nov; 55(11):1451-6. PubMed ID: 17046546
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peroxovanadate and insulin action in adipocytes from NIDDM patients. Evidence against a primary defect in tyrosine phosphorylation.
    Yu ZW; Jansson PA; Posner BI; Smith U; Eriksson JW
    Diabetologia; 1997 Oct; 40(10):1197-203. PubMed ID: 9349602
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of insulin-stimulated insulin receptor activation and glucose transport in cultured skeletal muscle cells from obese subjects.
    Pender C; Goldfine ID; Kulp JL; Tanner CJ; Maddux BA; MacDonald KG; Houmard JA; Youngren JF
    Metabolism; 2005 May; 54(5):598-603. PubMed ID: 15877289
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of NIDDM on the glucose transport system in human skeletal muscle.
    Scheck SH; Barnard RJ; Lawani LO; Youngren JF; Martin DA; Singh R
    Diabetes Res; 1991 Mar; 16(3):111-9. PubMed ID: 1802477
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Altered glucose homeostasis in mice lacking the receptor protein tyrosine phosphatase sigma.
    Chagnon MJ; Elchebly M; Uetani N; Dombrowski L; Cheng A; Mooney RA; Marette A; Tremblay ML
    Can J Physiol Pharmacol; 2006 Jul; 84(7):755-63. PubMed ID: 16998539
    [TBL] [Abstract][Full Text] [Related]  

  • 36. {beta}-Hydroxybutyrate inhibits insulin-mediated glucose transport in mouse oxidative muscle.
    Yamada T; Zhang SJ; Westerblad H; Katz A
    Am J Physiol Endocrinol Metab; 2010 Sep; 299(3):E364-73. PubMed ID: 20516259
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Leptin down-regulates insulin action through phosphorylation of serine-318 in insulin receptor substrate 1.
    Hennige AM; Stefan N; Kapp K; Lehmann R; Weigert C; Beck A; Moeschel K; Mushack J; Schleicher E; Häring HU
    FASEB J; 2006 Jun; 20(8):1206-8. PubMed ID: 16611834
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin-receptor tyrosine kinase activity is decreased in erythrocytes from non-obese patients with NIDDM.
    Santos RF; Palmieri MG; Wajchenberg BL; Azhar S
    Horm Metab Res; 1994 Jun; 26(6):283-7. PubMed ID: 7927191
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blockade of the Renin-Angiotensin system improves insulin receptor signaling and insulin-stimulated skeletal muscle glucose transport in burn injury.
    Kasper SO; Phillips EE; Castle SM; Daley BJ; Enderson BL; Karlstad MD
    Shock; 2011 Jan; 35(1):80-5. PubMed ID: 20823693
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure-activity relationship of synthetic phosphoinositolglycans mimicking metabolic insulin action.
    Frick W; Bauer A; Bauer J; Wied S; Müller G
    Biochemistry; 1998 Sep; 37(38):13421-36. PubMed ID: 9748349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.